The Reply

Affiliations

¹ Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK; Department of Life Sciences, School of Sciences, European University of Cyprus, Nicosia.
² Muirhouse Medical Group, Edinburgh, UK; Centre for Population Health Sciences, University of Edinburgh, UK.
³ Department of Clinical and Health Psychology, University of Edinburgh, UK.
⁴ Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK; Muirhouse Medical Group, Edinburgh, UK.
⁵ Department of Medicine, University of East Anglia, Norwich, UK.
⁶ Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK.

Comment

Antonia Sophocleous et al. Am J Med. 2017 Oct.

. 2017 Oct;130(10):e457.

doi: 10.1016/j.amjmed.2017.05.033.

¹ Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK; Department of Life Sciences, School of Sciences, European University of Cyprus, Nicosia.
² Muirhouse Medical Group, Edinburgh, UK; Centre for Population Health Sciences, University of Edinburgh, UK.
³ Department of Clinical and Health Psychology, University of Edinburgh, UK.
⁴ Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK; Muirhouse Medical Group, Edinburgh, UK.
⁵ Department of Medicine, University of East Anglia, Norwich, UK.
⁶ Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK.

No abstract available

Comment on

Heavy Cannabis Use Is Associated With Low Bone Mineral Density and an Increased Risk of Fractures.
Sophocleous A, Robertson R, Ferreira NB, McKenzie J, Fraser WD, Ralston SH. Sophocleous A, et al. Am J Med. 2017 Feb;130(2):214-221. doi: 10.1016/j.amjmed.2016.07.034. Epub 2016 Sep 2. Am J Med. 2017. PMID: 27593602
Is Determination of Predictors by Cross-Sectional Study Valid?
Hanis SM, Mansori K. Hanis SM, et al. Am J Med. 2017 Oct;130(10):e455. doi: 10.1016/j.amjmed.2017.03.047. Epub 2017 May 26. Am J Med. 2017. PMID: 28552165 No abstract available.
An Opioid Contribution to Low Bone Mineral Density in Cannabis Smokers.
Daniell HW. Daniell HW. Am J Med. 2017 Oct;130(10):e453. doi: 10.1016/j.amjmed.2017.03.048. Am J Med. 2017. PMID: 28927540 No abstract available.